Advancing the Therapeutic Potential of Indoleamides for Tuberculosis

Indole-2-carboxamide derivatives are inhibitors of MmpL3, the cell wall-associated mycolic acid transporter of Mycobacterium tuberculosis. In the present study, we characterized indoleamide effects on bacterial cell morphology and reevaluated pharmacokinetics and in vivo efficacy using an optimized...

詳細記述

保存先:
書誌詳細
出版年:Antimicrob Agents Chemother
主要な著者: Lun, Shichun, Tasneen, Rokeya, Chaira, Tridib, Stec, Jozef, Onajole, Oluseye K., Yang, Tian J., Cooper, Christopher B., Mdluli, Khisi, Converse, Paul J., Nuermberger, Eric L., Raj, V. Samuel, Kozikowski, Alan, Bishai, William R.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2019
主題:
Experimental Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591635/
https://ncbi.nlm.nih.gov/pubmed/31010860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00343-19
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料